The now and future health ecosystem: Online presentation available

As healthcare consumers, Baby Boomers and Millennials have widely varying—and sometimes sharply competing—priorities, preferences and demands. Combined with technology-driven innovation, the situation is setting up a “Copernican moment” for healthcare organizations.

So writes Forbes contributor Dave Chase by way of introducing “The Future Health Ecosystem Today,” a 94-slide online presentation examining the forces, trends and demands transforming the industry.

“It’s no longer a marketing trope to be ‘patient-centric’—it’s a matter of survival,” writes Chase of one of the main challenges from the provider’s eye view. “In the past, behavior outside the clinic had little impact on healthcare providers. Going forward, it will be central to providers’ success (or failure).”

Click the link below to access Chase’s intro and a link to the slideshow:

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.